不明原因栓塞性卒中:心脏监测与抗凝治疗的新数据与新争议
不明原因栓塞性卒中占所有缺血性卒中的9%-25%。4项随机对照试验未能证实通用抗凝优于阿司匹林预防复发,多项随机对照试验显示延长心脏监测可提高心房颤动检出和抗凝启动,但未降低卒中复发。本文综述近期抗血栓治疗随机对照试验的临床与研究启示。
要点
- 不明原因栓塞性卒中占缺血性卒中9%-25%。
- 4项随机对照试验未证实通用抗凝优于阿司匹林预防卒中复发。
- 延长心脏监测提高心房颤动检出和抗凝启动,但未降低卒中复发。
核心结论
- 4项随机对照试验未能证实通用抗凝优于阿司匹林预防不明原因栓塞性卒中复发。
- 延长心脏监测提高心房颤动检出和抗凝启动,但随机对照试验及后续Meta分析均未显示卒中复发减少。
研究设计与样本
- 综述,总结近期不明原因栓塞性卒中及设备检测无症状心房颤动高危人群的抗血栓治疗随机对照试验。
主要发现
- 不明原因栓塞性卒中占所有缺血性卒中的9%-25%。
- 4项随机对照试验患者选择程度不同,均未证实通用抗凝优于阿司匹林预防复发。
- 多项随机对照试验一致显示延长心脏监测较常规护理提高心房颤动检出和抗凝启动。
- 延长心脏监测的随机对照试验及后续Meta分析均未显示卒中复发减少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Embolic strokes of undetermined source (ESUS) represent 9%-25% of all ischemic strokes. Based on the suspicion that a large proportion of cardioembolic sources remain undetected among embolic stroke of undetermined source patients, it has been hypothesized that a universal approach of anticoagulation would be better than aspirin for preventing recurrent strokes. However, 4 randomized controlled trials (RCTs), with different degrees of patient selection, failed to confirm this hypothesis. In parallel, several RCTs consistently demonstrated that prolonged cardiac monitoring increased atrial fibrillation detection and anticoagulation initiation compared with usual care in patients with ESUS, and later in individuals with ischemic stroke of known cause (e.g., large or small vessel disease). However, none of these trials or subsequent meta-analyses of all available RCTs have shown a reduction in stroke recurrence associated with the use of prolonged cardiac monitoring. In this article, we review the clinical and research implications of recent RCTs of antithrombotic therapy in patients with ESUS and in high-risk populations with and without stroke, with device-detected asymptomatic atrial fibrillation.
引用
- Sposato LA, Sur NB, Katan M, et al. Embolic Stroke of Undetermined Source: New Data and New Controversies on Cardiac Monitoring and Anticoagulation. Neurology. 2024. PMID: 38861698. doi:10.1212/WNL.0000000000209535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。